GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Institutional Ownership

BML (BMLKF) Institutional Ownership : 26.05% (As of May. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is BML Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BML's institutional ownership is 26.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BML's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BML's Float Percentage Of Total Shares Outstanding is 0.00%.


BML Institutional Ownership Historical Data

The historical data trend for BML's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BML Institutional Ownership Chart

BML Historical Data

The historical data trend for BML can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 27.70 28.13 28.82 27.40 27.57 26.65 26.73 26.72 26.09 26.05

BML Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


BML (BMLKF) Business Description

Traded in Other Exchanges
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.